Neuroimmune Modulation

Advertisement

cGxPJobs Banner

SetPoint Medical Delivers First FDA-Approved RA Device in N.C.

VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...

By cGxPwire Editor
June 30, 2026

Read More

Zymeworks Launches $125M Share Repurchase Program

VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...

By cGxPwire Editor
May 16, 2026

Read More

SetPoint System Could Cut Lifetime RA Care Costs by $350,000

VALENCIA, Calif., May 14, 2026 SetPoint Medical announced the publication of a peer-reviewed health economics study demonstrating that its...

By cGxPwire Editor
May 16, 2026

Read More

SetPoint Medical Starts MS Study for Neuroimmune Therapy

VALENCIA, California, April 30, 2026 SetPoint Medical announced the first patients enrolled in a pilot clinical study evaluating its...

By cGxPwire Editor
May 1, 2026

Read More

Advertisement

cGxPJobs

Directory